Symbiox Investment & Trading Co Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 999951,
    "name": "Symbiox Investme",
    "stock_name": "Symbiox Investme",
    "full_name": "Symbiox Investment & Trading Co Ltd",
    "name_url": "stocks-analysis/symbiox-investme",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1.99",
    "chg": 0.09,
    "chgp": "4.74%",
    "dir": 1,
    "prev_price": "1.90",
    "mcapval": "6.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 539278,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 5,
    "indexname": "",
    "isin": "INE653R01012",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "33.26 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/symbiox-investme-999951-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Symbiox Investme falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-symbiox-investme-fallingrising-3745031",
        "imagepath": "",
        "date": "2025-12-04 00:55:47",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Comparison</strong></p>\n<p>Symbiox’s share price has been under pressure over multiple time frames. In the past week, the stock fell by 3.62%, significantly underperforming the Sensex, which declined by only 0.59%. The one-month performance further highlights this divergence, with Symbiox dropping 8.59% while the Sensex gained 1.34%. Year-to-date figures reveal a stark contrast: the stock has plummeted by 50.92%, whereas the Sensex has risen by 8.92%. Over the last year, the stock’s decline of 30.18% contrasts with the Sensex’s 5.27% gain, and the three-year performance shows a severe 63.16% fall against a robust 35.37% rise in the benchmark. Even over five years, despite a cumulative gain of 153.33%, Symbiox’s growth trails the Sensex’s 90.68% by a narrower ..."
      },
      {
        "title": "Symbiox Investment & Trading Co Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-faces-severe-selling-pressure-amid-lower-circuit-3744470",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SymbioxInvestme_only_sellers_3744470.png",
        "date": "2025-12-03 15:25:54",
        "description": "Symbiox Investment & Trading Co Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an absence of buyers in the market. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market indices."
      },
      {
        "title": "Symbiox Investment & Trading Co Experiences Unprecedented Buying Interest Amidst Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-hits-upper-circuit-amidst-unprecedented-buying-interest-3738197",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SymbioxInvestme_only_buyers_3738197.png",
        "date": "2025-12-01 10:40:48",
        "description": "Symbiox Investment & Trading Co Ltd has attracted extraordinary buying interest today, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights a strong demand for the stock despite recent underperformance relative to broader indices and its sector peers."
      },
      {
        "title": "Symbiox Investment & Trading Co Sees Unprecedented Buying Interest Amid Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-surges-on-extraordinary-buying-interest-amid-upper-circuit-3733664",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SymbioxInvestme_only_buyers_3733664.png",
        "date": "2025-11-27 12:25:56",
        "description": "Symbiox Investment & Trading Co Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an exclusive queue of buy orders dominating the market. This rare scenario, marked by an absence of sellers, signals a potential multi-day circuit phenomenon that has captured investor attention in the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Symbiox Investment & Trading Co Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-faces-severe-selling-pressure-amid-lower-circuit-3731319",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SymbioxInvestme_only_sellers_3731319.png",
        "date": "2025-11-26 11:25:50",
        "description": "Symbiox Investment & Trading Co Ltd is currently experiencing severe selling pressure, with the stock registering consecutive declines and no visible buying interest. The Non Banking Financial Company (NBFC) has seen its shares fall sharply over multiple time frames, signalling distress selling and a challenging market environment for investors."
      },
      {
        "title": "Symbiox Investment & Trading Co Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3728921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SymbioxInvestme_only_sellers_3728921.png",
        "date": "2025-11-25 11:26:16",
        "description": "Symbiox Investment & Trading Co Ltd, a player in the Non Banking Financial Company (NBFC) sector, is currently experiencing severe selling pressure, with only sell orders present in the market queue. This unusual trading pattern signals distress selling and highlights the challenges the stock faces amid broader market fluctuations."
      },
      {
        "title": "Symbiox Investment & Trading Co Ltd Faces Significant Selling Pressure with 1.67% Decline Today",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-faces-significant-selling-pressure-with-167-decline-today-3701904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SymbioxInvestme_only_sellers_3701904.png",
        "date": "2025-11-14 15:25:53",
        "description": "Symbiox Investment & Trading Co Ltd is experiencing notable selling pressure, continuing a trend of losses. The stock has declined significantly over various time frames, contrasting with the performance of the Sensex. Factors such as market sentiment and operational challenges in the NBFC sector may be influencing this downturn."
      },
      {
        "title": "Is Symbiox Investme overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-symbiox-investme-overvalued-or-undervalued-3700241",
        "imagepath": "",
        "date": "2025-11-14 08:11:47",
        "description": "As of 13 November 2025, the valuation grade for Symbiox Investme has moved from attractive to risky. This indicates a significant deterioration in its valuation outlook, leading to the conclusion that the company is overvalued. The PE ratio stands at an alarming -938.62, while the EV to EBIT and EV to EBITDA ratios are both at 4.74, suggesting inefficiencies in generating earnings relative to its enterprise value.\n\nWhen compared to peers, Symbiox Investme's ratios starkly contrast with those of Bajaj Finance, which has a PE ratio of 34.18, and Life Insurance, which boasts a PE of 11.18. The negative return on equity (ROE) of -0.03% further underscores the company's struggles, especially when juxtaposed with the more stable financial metrics of its competitors. Despite a recent uptick in stock performance relative to the Sensex over the past week and month, the broader year-to-date and one-year returns of -4..."
      },
      {
        "title": "Symbiox Investment & Trading Co Ltd Faces 5% Decline Amid Significant Selling Pressure Today",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/symbiox-investment-trading-co-ltd-faces-5-decline-amid-significant-selling-pressure-today-3697815",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SymbioxInvestme_only_sellers_3697815.png",
        "date": "2025-11-13 14:20:29",
        "description": "Symbiox Investment & Trading Co Ltd is experiencing significant selling pressure, with a notable decline today amid a contrasting performance from the Sensex. The stock has faced consecutive losses, underperforming both weekly and yearly benchmarks, reflecting broader market trends and sector-specific concerns."
      }
    ],
    "total": 518,
    "sid": "999951",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/symbiox-investment-trading-co-999951"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Meeting To Be Held On 7Th February 2026.",
      "datetime": "31-Jan-2026",
      "details": "Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia to consider and approve Unaudited Financial Results for Quarter ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Dec-2025",
      "details": "INTIMATION OF BOOK CLOSURE",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Symbiox Investme falling/rising?

2025-12-04 00:55:47

Recent Price Movement and Market Comparison Symbiox’s share price has been under pressure over multiple time frames. In the past week, the stock fell by 3.62%, significantly underperforming the Sensex, which declined by only 0.59%. The one-month performance further highlights this divergence, with Symbiox dropping 8.59% while the Sensex gained 1.34%. Year-to-date figures reveal a stark contrast: the stock has plummeted by 50.92%, whereas the Sensex has risen by 8.92%. Over the last year, the stock’s decline of 30.18% contrasts with the Sensex’s 5.27% gain, and the three-year performance shows a severe 63.16% fall against a robust 35.37% rise in the benchmark. Even over five years, despite a cumulative gain of 153.33%, Symbiox’s growth trails the Sensex’s 90.68% by a narrower ...

Symbiox Investment & Trading Co Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-12-03 15:25:54

Symbiox Investment & Trading Co Ltd is currently experiencing severe selling pressure, with the stock hitting a lower circuit and an absence of buyers in the market. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market indices.

Symbiox Investment & Trading Co Experiences Unprecedented Buying Interest Amidst Market Challenges

2025-12-01 10:40:48

Symbiox Investment & Trading Co Ltd has attracted extraordinary buying interest today, with the stock hitting an upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights a strong demand for the stock despite recent underperformance relative to broader indices and its sector peers.

Symbiox Investment & Trading Co Sees Unprecedented Buying Interest Amid Upper Circuit

2025-11-27 12:25:56

Symbiox Investment & Trading Co Ltd has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and an exclusive queue of buy orders dominating the market. This rare scenario, marked by an absence of sellers, signals a potential multi-day circuit phenomenon that has captured investor attention in the Non Banking Financial Company (NBFC) sector.

Symbiox Investment & Trading Co Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-26 11:25:50

Symbiox Investment & Trading Co Ltd is currently experiencing severe selling pressure, with the stock registering consecutive declines and no visible buying interest. The Non Banking Financial Company (NBFC) has seen its shares fall sharply over multiple time frames, signalling distress selling and a challenging market environment for investors.

Symbiox Investment & Trading Co Faces Intense Selling Pressure Amid Market Downturn

2025-11-25 11:26:16

Symbiox Investment & Trading Co Ltd, a player in the Non Banking Financial Company (NBFC) sector, is currently experiencing severe selling pressure, with only sell orders present in the market queue. This unusual trading pattern signals distress selling and highlights the challenges the stock faces amid broader market fluctuations.

Symbiox Investment & Trading Co Ltd Faces Significant Selling Pressure with 1.67% Decline Today

2025-11-14 15:25:53

Symbiox Investment & Trading Co Ltd is experiencing notable selling pressure, continuing a trend of losses. The stock has declined significantly over various time frames, contrasting with the performance of the Sensex. Factors such as market sentiment and operational challenges in the NBFC sector may be influencing this downturn.

Is Symbiox Investme overvalued or undervalued?

2025-11-14 08:11:47

As of 13 November 2025, the valuation grade for Symbiox Investme has moved from attractive to risky. This indicates a significant deterioration in its valuation outlook, leading to the conclusion that the company is overvalued. The PE ratio stands at an alarming -938.62, while the EV to EBIT and EV to EBITDA ratios are both at 4.74, suggesting inefficiencies in generating earnings relative to its enterprise value. When compared to peers, Symbiox Investme's ratios starkly contrast with those of Bajaj Finance, which has a PE ratio of 34.18, and Life Insurance, which boasts a PE of 11.18. The negative return on equity (ROE) of -0.03% further underscores the company's struggles, especially when juxtaposed with the more stable financial metrics of its competitors. Despite a recent uptick in stock performance relative to the Sensex over the past week and month, the broader year-to-date and one-year returns of -4...

Symbiox Investment & Trading Co Ltd Faces 5% Decline Amid Significant Selling Pressure Today

2025-11-13 14:20:29

Symbiox Investment & Trading Co Ltd is experiencing significant selling pressure, with a notable decline today amid a contrasting performance from the Sensex. The stock has faced consecutive losses, underperforming both weekly and yearly benchmarks, reflecting broader market trends and sector-specific concerns.

View All News